The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Viking Therapeutics Inc shares valued at $8,313,601 were sold by Lian Brian on Jan 06 ’25. At $42.75 per share, Lian Brian sold 194,490 shares. The insider’s holdings dropped to 2,366,570 shares worth approximately $96.08 million following the completion of this transaction.
Also, Mancini Marianna sold 54,215 shares, netting a total of over 2,317,599 in proceeds. Following the sale of shares at $42.75 each, the insider now holds 374,134 shares.
Before that, ZANTE GREG had sold 50,309 shares from its account. In a trade valued at $2,150,595, the Chief Financial Officer traded Viking Therapeutics Inc shares for $42.75 each. Upon closing the transaction, the insider’s holdings decreased to 50,309 shares, worth approximately $6.71 million.
As published in their initiating research note from Piper Sandler on December 02, 2024, Viking Therapeutics Inc [VKTX] has been an Overweight. Analysts at B. Riley Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in late November. As of November 04, 2024, H.C. Wainwright has reiterated its “Buy” rating for VKTX. Earlier on September 11, 2024, JP Morgan initiated its rating. Their recommendation was “an Overweight” for VKTX stock.
Analyzing VKTX Stock Performance
During the last five days, there has been a surge of approximately 0.89%. Over the course of the year, Viking Therapeutics Inc shares have jumped approximately 0.89%. Shares of the company reached a 52-week high of $43.55 on 01/06/25 and a 52-week low of $40.31 on 01/08/25. A 50-day SMA is recorded $52.33, while a 200-day SMA reached $60.29. Nevertheless, trading volume fell to 2.0 million shares from 2.01 million shares the previous day.
Support And Resistance Levels for Viking Therapeutics Inc (VKTX)
According to the 24-hour chart, there is a support level at 40.07, which, if violated, would cause prices to drop to 39.55. In the upper region, resistance lies at 41.36. The next price resistance is at 42.13. RSI (Relative Strength Index) is 36.02 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.22, which suggests the price will decrease in the coming days. Percent R is at 61.11%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
